Physician profile
Mark D Oberlander
NPI 1245292176
$2,439.11
in general payments reported to CMS, 2019-2025
16 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $119 · 2021: $210 · 2022: $245 · 2023: $182 · 2024: $255 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $966.45 | 2019-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Allergan, INC. | $343.57 | 2019-2021 | |
| Amgen INC. | $266.37 | 2024-2025 | Tepezza |
| Rxsight INC | $252.85 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Abbvie INC. | $170.20 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $53.73 | 2019-2021 | |
| Glaukos Corporation | $52.22 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $42.70 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $38.19 | 2019-2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $31.98 | 2022 | |
| Sun Pharmaceutical Industries INC. | $24.40 | 2021 | |
| Bausch & Lomb Americas INC. | $23.92 | 2025 | Miebo |
| Oyster Point Pharma, INC. | $21.38 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.25 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Oberlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.